S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
OTCMKTS:EMBI

Emerald Bioscience Stock Forecast, Price & News

$0.09
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.09
Now: $0.09
$0.10
50-Day Range
$0.03
MA: $0.04
$0.09
52-Week Range
$0.02
Now: $0.09
$0.20
Volume12.61 million shs
Average Volume14.23 million shs
Market Capitalization$23.72 million
P/E RatioN/A
Dividend YieldN/A
Beta0.43
Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1237th out of 1,480 stocks

Pharmaceutical Preparations Industry

545th out of 612 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EMBI
CUSIPN/A
CIKN/A
Phone949-336-3443
Employees4

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$1.05 million

Miscellaneous

Market Cap$23.72 million
Next Earnings Date3/19/2021 (Estimated)
OptionableNot Optionable
$0.09
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EMBI News and Ratings via Email

Sign-up to receive the latest news and ratings for EMBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Emerald Bioscience (OTCMKTS:EMBI) Frequently Asked Questions

How has Emerald Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Emerald Bioscience's stock was trading at $0.0850 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EMBI shares have increased by 4.1% and is now trading at $0.0885.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Emerald Bioscience?

Wall Street analysts have given Emerald Bioscience a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Emerald Bioscience wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Emerald Bioscience's next earnings date?

Emerald Bioscience is scheduled to release its next quarterly earnings announcement on Friday, March 19th 2021.
View our earnings forecast for Emerald Bioscience
.

Who are some of Emerald Bioscience's key competitors?

What other stocks do shareholders of Emerald Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Bioscience investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Charlotte's Web (CWBHF), (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cognex (CGNX), Cumberland Pharmaceuticals (CPIX), Corbus Pharmaceuticals (CRBP) and Editas Medicine (EDIT).

Who are Emerald Bioscience's key executives?

Emerald Bioscience's management team includes the following people:
  • Mr. Punit S. Dhillon B.A., BA, Exec. Chairman & CEO (Age 40, Pay $65k)
  • Mr. Richard Janney, Interim Principal Accounting Officer
  • Ms. Elena Traistaru, Company Sec. (Age 61)

What is Emerald Bioscience's stock symbol?

Emerald Bioscience trades on the OTCMKTS under the ticker symbol "EMBI."

How do I buy shares of Emerald Bioscience?

Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Emerald Bioscience's stock price today?

One share of EMBI stock can currently be purchased for approximately $0.09.

How big of a company is Emerald Bioscience?

Emerald Bioscience has a market capitalization of $23.72 million. Emerald Bioscience employs 4 workers across the globe.

What is Emerald Bioscience's official website?

The official website for Emerald Bioscience is www.emeraldbio.life.

How can I contact Emerald Bioscience?

Emerald Bioscience's mailing address is 130 NORTH MARINA DRIVE, LONG BEACH CA, 90803. The company can be reached via phone at 949-336-3443 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.